Can a single pill speed up severe flu recovery?
NCT ID NCT06653569
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a single dose of baloxavir marboxil (Xofluza) can help adults hospitalized with severe flu recover faster. About 484 participants in Switzerland will receive either the drug or a placebo. Researchers will measure time to clinical improvement, hospital stay length, and complication rates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- baloxavir marboxil (Xofluza)
- What this could lead to
- If it works, this could provide a faster recovery option for people hospitalized with severe flu, reducing hospital stays and complications.
- What could go wrong
- This is a Phase 3 trial, but results may not apply to all flu strains or patient groups. The placebo group also receives standard care, so the added benefit may be small.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA DISEASE; FLU are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Geneva University Hospitals
RECRUITINGGeneva, Canton of Geneva, 1205, Switzerland